✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Ind-Swift Laboratories Ltd.

INDSWFTLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹762 Cr.
P/E
3.19

Ind-Swift Laboratories Ltd.

  • Ind-Swift Lab.
  • Bharat Parenterals
  • Anuh Pharma

FAQs on Ind-Swift Laboratories Ltd. Shareprice

Ind-Swift Lab. has given lower returns compared to its competitors.
Ind-Swift Lab. has grown at ~8.65% over the last 7yrs while peers have grown at a median rate of 24.92%

Ind-Swift Lab. is not expensive.
Latest PE of Ind-Swift Lab. is 3.27, while 3 year average PE is 8.35.
Also latest EV/EBITDA of Ind-Swift Lab. is 0.0 while 3yr average is 4.73.

View FAQ's On Business

Growth Table

  • Ind-Swift Laboratories Ltd.
  • Bharat Parenterals
  • Anuh Pharma

Balance Sheet

  • Ind-Swift Laboratories Ltd.
  • Bharat Parenterals
  • Anuh Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Ind-Swift Laboratories Ltd.
  • Bharat Parenterals
  • Anuh Pharma

Cash Flow

  • Ind-Swift Laboratories Ltd.
  • Bharat Parenterals
  • Anuh Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Ind-Swift Laboratories Ltd.
  • Bharat Parenterals
  • Anuh Pharma

Quarterly Results

  • Ind-Swift Laboratories Ltd.
  • Bharat Parenterals
  • Anuh Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Ind-Swift Laboratories Ltd. Financials

Balance sheet of Ind-Swift Lab. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Ind-Swift Lab. is increasing.
Latest net debt of Ind-Swift Lab. is -₹378.1 Crs as of Sep-25.
This is greater than Mar-25 when it was -₹821.6 Crs.

No, profit is decreasing.
The profit of Ind-Swift Lab. is ₹239 Crs for TTM, ₹250 Crs for Mar 2025 and ₹421 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Ind-Swift Lab. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech